Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers
Top Cited Papers
- 1 December 2003
- journal article
- Published by Elsevier in Kidney International
- Vol. 64 (6) , 2272-2279
- https://doi.org/10.1046/j.1523-1755.2003.00328.x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked HypophosphatemiaNew England Journal of Medicine, 2003
- Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalaciaActa Endocrinologica, 2003
- Cardiovascular calcification in patients with end-stage renal disease: A century-old phenomenonKidney International, 2002
- Hyperphosphataemia as a cardiovascular risk factor - how to manage the problemNephrology Dialysis Transplantation, 2002
- Increased Circulatory Level of Biologically Active Full-Length FGF-23 in Patients with Hypophosphatemic Rickets/OsteomalaciaJournal of Clinical Endocrinology & Metabolism, 2002
- Mutant FGF-23 Responsible for Autosomal Dominant Hypophosphatemic Rickets Is Resistant to Proteolytic Cleavage and Causes Hypophosphatemia in VivoEndocrinology, 2002
- Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failureAmerican Journal of Kidney Diseases, 2002
- Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalaciaProceedings of the National Academy of Sciences, 2001
- The Autosomal Dominant Hypophosphatemic Rickets (ADHR) Gene Is a Secreted Polypeptide Overexpressed by Tumors that Cause Phosphate WastingJournal of Clinical Endocrinology & Metabolism, 2001
- Dietary Phosphate Deprivation in Women and Men: Effects on Mineral and Acid Balances, Parathyroid Hormone and the Metabolism of 25-OH-Vitamin D*Journal of Clinical Endocrinology & Metabolism, 1976